Goldman Sachs and Charlesbank acquire MDVIP

Goldman Sachs and Charlesbank have closed its acquisition of MDVIP from Leonard Green & Partners and Summit Partners.

Goldman Sachs and Charlesbank have closed its acquisition of MDVIP from Leonard Green & Partners and Summit Partners. No financial terms were disclosed. MDVIP is a provider of personalized membership-based healthcare.

PRESS RELEASE

BOCA RATON, Fla. – October 14, 2021 – MDVIP, the national leader in personalized membership-based healthcare, today announced that the Private Equity business within Goldman Sachs Asset Management (“Goldman Sachs”) and funds affiliated with Charlesbank Capital Partners (“Charlesbank”) have completed the acquisition of MDVIP from Leonard Green & Partners and Summit Partners. The transaction gives Goldman Sachs and Charlesbank majority ownership of the company. Financial terms were not disclosed.

MDVIP leads the market in membership-based medicine with a national network of approximately 1,100 primary care physicians serving 362,000 patients. In the MDVIP model, doctors maintain smaller practices, which enables them to spend more time with patients and provide more attentive, individualized care compared to traditional, high-volume practices. Patients receive the MDVIP Wellness Program, a comprehensive yearly health assessment that includes advanced diagnostic tests and screenings to give a more complete picture of their overall health. Using the results, physicians provide education and coaching to help patients make healthier lifestyle choices, prevent disease and achieve their wellness goals.

“For more than two decades, MDVIP has redefined primary care for both physicians and patients to enhance their experience and improve healthcare outcomes,” said MDVIP Chairman and CEO Bret Jorgensen, who will continue to lead the company. “With this investment from Goldman Sachs and Charlesbank, MDVIP is ideally positioned to advance its strategic growth initiatives and continue expanding its portfolio of services to meet increasing demand for more personalized care.”

Commenting on the acquisition, Jo Natauri, Partner and Global Head of Private Healthcare Investing within Goldman Sachs Asset Management, said, “MDVIP has differentiated itself with a proven model, national footprint, reputation and patient satisfaction scores that exceed healthcare industry benchmarks. We are excited to collaborate with Charlesbank and the MDVIP management team to build on the company’s leadership and strengths in primary care.”

“We are pleased to have completed the MDVIP transaction with our partners at Goldman Sachs,” added Brandon White, Managing Director at Charlesbank Capital Partners. “MDVIP has developed a highly successful business model with multiple avenues for growth, and we look forward to supporting their continued momentum.”

About MDVIP
MDVIP leads the market in membership-based healthcare that goes far beyond concierge medicine services with a national network of approximately 1,100 primary care physicians serving 362,000 patients. MDVIP-affiliated physicians limit the size of their practices, which affords them the time needed to provide patients with more individualized service and attention, including an annual, comprehensive preventive care program and customized wellness plan. Published research shows that the MDVIP model identifies more patients at risk for cardiovascular disease, delivers more preventive health services and saves the healthcare system hundreds of millions of dollars through reduced hospitalizations and readmissions. In response to growing consumer demand for a more personalized healthcare experience, hospital systems are incorporating the MDVIP model into their primary care offering. MDVIP is also partnering with employers to offer an executive health program as a benefit to their employees. The company, which celebrated its 20th anniversary last year, has been certified by Great Place to Work since 2018 and is recognized by Fortune as one of the 2021 Best Workplaces in Healthcare. For more information, visit www.mdvip.com or follow on LinkedIn.